Challenges and Opportunities in the Management of Multi-Drug Resistant HIV

Dr McCray shares an encounter with “Patient X”, highlighting the barriers and challenges associated with MDR therapies in HIV treatment.

Dr McCray shares an encounter with “Patient X”, highlighting the barriers and challenges associated with MDR therapies in HIV treatment.

Health disparities in HIV treatment management are discussed by Drs Peskin and McCray.

Steven Peskin, M.D., MBA, FACP, discusses considerations for payers when identifying patients at risk for drug-resistant HIV.

Medical experts provide an overview of testing considerations for MDR HIV.

Non–treatment-naïve patient considerations are explored by key opinion leaders.

Dr. Peskin identifies the significance of payer support in the treatment landscape of MDR HIV.

Treatment barriers inhibit optimal care for many patients diagnosed with HIV.

Drs McCray and Peskin provide an overview of the CAPELLA trial.

In their final thoughts, Eugene McCray, M.D., and Steven Peskin, M.D., MBA, FACP, share insights into unmet needs surrounding HIV treatment management.